PEOPLE - Jerneen, the wholly owned subsidiary of US company Bio-Vascular (US) makes promotion:
This article was originally published in Clinica
Fariborz BoorBoor has been promoted to vice-president and chief operating officer of Jerneen, the wholly owned subsidiary of US company Bio-Vascular.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.